31 Mar 2022
Assets17.74
Total Income22.58
Profit After Tax0.08
NET Worth3.08
Total Borrowing7.61
Financial performance
Year-wise operating scale, profitability and balance-sheet context.Revenue35.75₹ Cr · +5.3% vs prior year
PAT5.24₹ Cr · +35.1% vs prior year
Assets39.99₹ Cr · +47.8% vs prior year
Net Worth13.58₹ Cr · +153.8% vs prior year
Borrowing13.79₹ Cr · +2.3% vs prior year
3-year financial trendRevenue / EBITDA / PAT
₹ crore31 Mar 2023
Assets20.58
Total Income29.53
Profit After Tax0.10
NET Worth3.84
Total Borrowing8.47
31 Mar 2024
Assets27.05
Total Income33.94
Profit After Tax3.88
NET Worth5.35
Reserves and Surplus1.35
Total Borrowing13.48
31 Dec 2024
Assets39.99
Total Income35.75
Profit After Tax5.24
NET Worth13.58
Reserves and Surplus5.41
Total Borrowing13.79
IPO UPDATE ALERTS
Register for IPO Updates →Track Accretion Pharmaceuticals without missing an update
Register for subscription, GMP, allotment and listing notifications.